TriVascular Technologies (TRIV) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts TRIV Hot Sheet
Join SI Premium – FREE
TriVascular Technologies (NASDAQ: TRIV) reported Q2 EPS of ($0.73), in-line with the analyst estimate of ($0.73). Revenue for the quarter came in at $9.7 million versus the consensus estimate of $8.78 million.
For earnings history and earnings-related data on TriVascular Technologies (TRIV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s posts better-than-expected third-quarter comparable sales
- CS Disco, Inc (LAW) Misses Q3 EPS by 6c; offers guidance
- Option Care Health (OPCH) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
